Urolog. pro Praxi, 2010; 11(2): 86-89

Preoperative management of the patient with pheochromocytoma

MUDr.Tomáš Zelinka, prof.MUDr.Jiří Widimský, CSc.
Centrum pro výzkum, diagnostiku a terapii arteriální hypertenze
III. interní klinika, 1. LF a VFN, Praha

Pheochromocytomas and functional paragangliomas are catecholamine-producing tumors which present mostly with headache, sweating,

palpitations, and hypertension and may develop serious cardiovascular complications. Biochemical testing for pheochromocytoma

is mandatory in all subjects with incidentally discovered adrenal masses as prevention of adverse events during operation in case of

undiagnosed pheochromocytoma or functional paraganglioma. Medical pre-treatment with alfa-adrenoceptor antagonists is essential

for successful operation which is performed in most cases by minimal invasive surgery in such centers which have sufficient experience

in operating these tumors.

Keywords: pheochromocytoma, functional paraganglioma, adrenalectomy

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zelinka T, Widimský J. Preoperative management of the patient with pheochromocytoma. Urol. praxi. 2010;11(2):86-89.
Download citation

References

  1. Zelinka T, Eisenhofer G, Pacák K. Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice. Stress 2007; 10: 195-203. Go to original source... Go to PubMed...
  2. Kopetschke R, Slisko M, Kilisli A, et al. Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol 2009; 161: 355-361. Go to original source... Go to PubMed...
  3. Adler JT, Mack E, Chen H. Isolated adrenal mass in patients with a history of cancer: remember pheochromocytoma. Ann Surg Oncol 2007; 14: 2358-2362. Go to original source... Go to PubMed...
  4. Pacák K. Feochromocytom. Praha: Galén, 2008.
  5. Pacak K. Preoperative Management of the Pheochromocytoma Patient. J Clin Endocrinol Metab 2007; 92: 4069-4079. Go to original source... Go to PubMed...
  6. Eisenhofer G, Rivers G, Rosas AL, et al. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Saf 2007; 30: 1031-1062. Go to original source... Go to PubMed...
  7. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? Jama 2002; 287: 1427-1434. Go to original source... Go to PubMed...
  8. Vránková A, Škramlíková T, Widimský J jr., et al. Stanovení metanefrinu a normetanefrinu v krevní plazmě pomocí HPLC s elektrochemickou detekcí. Chem Listy 2009, přijato k publikaci.
  9. Baid SK, Lai EW, Wesley RA, et al. Brief Communication: Radiographic Contrast Infusion and Catecholamine Release in Patients With Pheochromocytoma. Ann Intern Med 2009; 150: 27-32. Go to original source... Go to PubMed...
  10. Zelinka T, Petrák O, Štrauch B, et al. Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension. Neuroimmunomodulation 2007; 14: 57-64. Go to original source... Go to PubMed...
  11. Lebuffe G, Dosseh ED, Tek G, et al. The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia 2005; 60: 439-444. Go to original source... Go to PubMed...
  12. Walz MK, Alesina PF, Wenger FA, et al. Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients. World J Surg 2006; 30: 899-908. Go to original source... Go to PubMed...
  13. Walz MK. Adrenalectomy for preservation of adrenocortical function. Indication and results. Chirurg 2009; 80: 99-104. Go to original source... Go to PubMed...
  14. Bravo EL. Pheochromocytoma: an approach to antihypertensive management. Ann N Y Acad Sci 2002; 970: 1-10. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.